These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21203974)

  • 1. SUMOylation of RIG-I positively regulates the type I interferon signaling.
    Mi Z; Fu J; Xiong Y; Tang H
    Protein Cell; 2010 Mar; 1(3):275-83. PubMed ID: 21203974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1.
    Yeon SH; Song MJ; Kang HR; Lee JY
    Immunology; 2015 Feb; 144(2):312-20. PubMed ID: 25158146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25.
    Pauli EK; Chan YK; Davis ME; Gableske S; Wang MK; Feister KF; Gack MU
    Sci Signal; 2014 Jan; 7(307):ra3. PubMed ID: 24399297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankrd17 positively regulates RIG-I-like receptor (RLR)-mediated immune signaling.
    Wang Y; Tong X; Li G; Li J; Deng M; Ye X
    Eur J Immunol; 2012 May; 42(5):1304-15. PubMed ID: 22328336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.
    Oshiumi H; Sakai K; Matsumoto M; Seya T
    Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner.
    Yang YK; Qu H; Gao D; Di W; Chen HW; Guo X; Zhai ZH; Chen DY
    J Biol Chem; 2011 Mar; 286(12):10568-80. PubMed ID: 21233210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
    Spengler JR; Patel JR; Chakrabarti AK; Zivcec M; García-Sastre A; Spiropoulou CF; Bergeron É
    J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-mediated negative regulation of RIG-I antiviral activity.
    Gack MU; Nistal-Villán E; Inn KS; García-Sastre A; Jung JU
    J Virol; 2010 Apr; 84(7):3220-9. PubMed ID: 20071582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
    Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
    J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein.
    Jiang J; Tang H
    Protein Cell; 2010 Dec; 1(12):1106-17. PubMed ID: 21213104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of RIG-I-mediated innate antiviral signaling by SEC14L1.
    Li MT; Di W; Xu H; Yang YK; Chen HW; Zhang FX; Zhai ZH; Chen DY
    J Virol; 2013 Sep; 87(18):10037-46. PubMed ID: 23843640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-Tuning of the RIG-I-Like Receptor/Interferon Regulatory Factor 3-Dependent Antiviral Innate Immune Response by the Glycogen Synthase Kinase 3/β-Catenin Pathway.
    Khan KA; Dô F; Marineau A; Doyon P; Clément JF; Woodgett JR; Doble BW; Servant MJ
    Mol Cell Biol; 2015 Sep; 35(17):3029-43. PubMed ID: 26100021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDA5 is SUMOylated by PIAS2β in the upregulation of type I interferon signaling.
    Fu J; Xiong Y; Xu Y; Cheng G; Tang H
    Mol Immunol; 2011 Jan; 48(4):415-22. PubMed ID: 21156324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response.
    Xu C; He X; Zheng Z; Zhang Z; Wei C; Guan K; Hou L; Zhang B; Zhu L; Cao Y; Zhang Y; Cao Y; Ma S; Wang P; Zhang P; Xu Q; Ling Y; Yang X; Zhong H
    J Virol; 2014 Oct; 88(19):11356-68. PubMed ID: 25056901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Innate immune responses against viral infection and its suppression by viral proteins].
    Oshiumi H; Matsumoto M; Seya T
    Yakugaku Zasshi; 2013; 133(3):323-8. PubMed ID: 23449408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation.
    Pan Y; Li R; Meng JL; Mao HT; Zhang Y; Zhang J
    J Immunol; 2014 May; 192(10):4758-64. PubMed ID: 24729608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type I and type III IFN gene expression.
    Nousiainen L; Sillanpää M; Jiang M; Thompson J; Taipale J; Julkunen I
    Innate Immun; 2013 Oct; 19(5):516-30. PubMed ID: 23405030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
    Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
    Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production.
    Nistal-Villán E; Gack MU; Martínez-Delgado G; Maharaj NP; Inn KS; Yang H; Wang R; Aggarwal AK; Jung JU; García-Sastre A
    J Biol Chem; 2010 Jun; 285(26):20252-61. PubMed ID: 20406818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor.
    Zhu J; Zhang Y; Ghosh A; Cuevas RA; Forero A; Dhar J; Ibsen MS; Schmid-Burgk JL; Schmidt T; Ganapathiraju MK; Fujita T; Hartmann R; Barik S; Hornung V; Coyne CB; Sarkar SN
    Immunity; 2014 Jun; 40(6):936-48. PubMed ID: 24931123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.